Content about Alzheimer's disease

January 2, 2014

Among patients with mild to moderate Alzheimer disease, a daily dosage of 2,000 IUs of vitamin E, compared to placebo, was effective in slowing functional decline and in reducing caregiver time in assisting patients, according to a study that appeared in the Jan. 1 issue of JAMA.

July 29, 2013

Dr. Reddy's Labs has launched a generic drug used to treat Alzheimer's disease, the company said.

July 9, 2013

The Food and Drug Administration has approved a generic drug for treating Alzheimer's disease, FDA records showed.

July 8, 2013

More than half of the estimated 5.4 million Americans with Alzheimer's disease and other forms of dementia are at risk of wandering and becoming lost, according to the National Institute on Aging, a figure that has prompted the federal government to develop a series of training videos for police.

April 4, 2013

The annual cost of treating dementia in the United States ranges from $157 billion to $215 billion, according to a new study by the RAND Corp.

March 12, 2013

Actavis is challenging Novartis' patent on a patch used to treat Alzheimer's disease, Actavis said.

December 3, 2012

Merck has started a clinical trial that it hopes will eventually enroll 1,700 patients to evaluate an experimental drug for Alzheimer's disease, the company said.

July 24, 2012

An experimental drug under development by Pfizer and a unit of Johnson & Johnson does not appear effective in Alzheimer's disease patients who carry a certain genotype, according to results of a late-stage clinical trial announced by Pfizer on Tuesday.

April 6, 2012

Sam's Club is offering free screenings for brain health at all of its stores that operate pharmacies this month, the retailer said Friday.

January 26, 2012

Pfizer is partnering with a division of Johnson & Johnson and a charity organization to launch an initiative to award funding to projects designed to improve the diagnostic identification and tracking of Alzheimer's disease.

January 17, 2012

A late-stage clinical trial to evaluate a drug in Alzheimer's disease patients came up short, the drug's developers said Tuesday.

December 23, 2011

Drug maker Bristol-Myers Squibb and the Gladstone Institutes will collaborate to find new ways to treat Alzheimer's disease, the two said Thursday.

November 15, 2011

Kenneth O’Leary, president and founder of Cara Inc., passed away Oct. 12 at home after a long struggle with Alzheimer’s disease.

September 22, 2011

Dr. Reddy's Labs has launched a drug for treating Alzheimer's disease, the company said.

June 7, 2011

Another generic drug maker has been given the green light to market its version of an Alzheimer's disease treatment.

June 2, 2011

The Food and Drug Administration has approved a generic drug for Alzheimer’s disease made by Teva Pharmaceutical Industries.

June 1, 2011

The Food and Drug Administration has approved a generic treatment for Alzheimer’s disease made by Actavis, the drug maker said Tuesday.

June 1, 2011

Sandoz has launched generic versions of treatments for Alzheimer’s disease, the generic pharmaceuticals division of Swiss drug maker Novartis said Wednesday.

April 11, 2011

A drug originally developed by scientists in the Soviet Union to treat allergies and currently under investigation by Pfizer and Medivation did not yield significant results in a late-stage clinical trial of patients with Huntington disease, a disorder that leads to cognitive decline, the companies said Monday.

January 17, 2011

Japanese drug maker Takeda Pharmaceutical has signed an agreement with Durham, N.C.-based Zinfandel Pharmaceuticals to develop a test for assessing Alzheimer’s disease risk in adults, the two companies said.

January 5, 2011

BOLOGNA, Italy — Data from a new study by scientists in Italy could help physicians calculate patients’ risks for Alzheimer’s disease and heart attacks. Researchers at the University of Bologna said they found a common genetic link between heart attacks and Alzheimer’s, according to results of a study published in the Journal of Alzheimer’s Disease.


November 7, 2010

According to a study published in the November edition of Alzheimer’s & Dementia: The Journal...

November 7, 2010

Eli Lilly's acquisition of a leader in molecular imaging development could boost its Alzheimer's disease...

November 3, 2010

Nearly 100 drugs are in development for treating Alzheimer’s disease, according to a new report...

© 2014 Drug Store News. All Rights Reserved.